OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2
Manon RagonnetâCronin, Rungtiwa Nutalai, Jiandong Huo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Manon RagonnetâCronin, Rungtiwa Nutalai, Jiandong Huo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Showing 6 citing articles:
SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern
Arturo Casadevall, Daniele Focosi
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 33
Arturo Casadevall, Daniele Focosi
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 33
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
Akshita Gupta, Angelina Konnova, Mathias Smet, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 30
Akshita Gupta, Angelina Konnova, Mathias Smet, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 30
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment
Daniele Focosi, Scott A. McConnell, David J. Sullivan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Daniele Focosi, Scott A. McConnell, David J. Sullivan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses
Paola Mazzetti, Pietro Giorgio Spezia, Anna-Lisa Capria, et al.
Journal of Clinical Virology Plus (2023) Vol. 3, Iss. 2, pp. 100149-100149
Open Access | Times Cited: 4
Paola Mazzetti, Pietro Giorgio Spezia, Anna-Lisa Capria, et al.
Journal of Clinical Virology Plus (2023) Vol. 3, Iss. 2, pp. 100149-100149
Open Access | Times Cited: 4
Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication
S. Das, Sreyashi Nath, Shahjahan, et al.
DARU Journal of Pharmaceutical Sciences (2024) Vol. 32, Iss. 2, pp. 801-823
Closed Access
S. Das, Sreyashi Nath, Shahjahan, et al.
DARU Journal of Pharmaceutical Sciences (2024) Vol. 32, Iss. 2, pp. 801-823
Closed Access
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
Akshita Gupta, Angelina Konnova, Mathias Smet, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Akshita Gupta, Angelina Konnova, Mathias Smet, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
